1422007-49-5 Usage
Description
(R)-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamine is a complex organic molecule characterized by a bicyclic structure, specifically a bicyclo[4.2.0]octa-1,3,5-triene ring system. This molecule is adorned with three methoxy groups and features a methylamine functional group attached to it. Its unique structural composition suggests potential applications in various fields, including organic synthesis and pharmaceutical or biological research.
Uses
Used in Organic Synthesis:
(R)-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamine is used as a building block in organic synthesis for the creation of more complex molecules. Its unique bicyclic structure and functional groups make it a valuable component in the synthesis of advanced organic compounds.
Used in Pharmaceutical Research:
(R)-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamine is used as a compound of interest in pharmaceutical research due to its potential biological properties. Its unique structure may offer novel interactions with biological targets, warranting further investigation into its possible therapeutic applications.
Used in Biological Research:
In biological research, (R)-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamine is used as a subject for exploring its interactions with biological systems. (R)-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamine's potential to engage with biological targets could lead to new insights in the fields of biochemistry and molecular biology.
Check Digit Verification of cas no
The CAS Registry Mumber 1422007-49-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,2,0,0 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1422007-49:
(9*1)+(8*4)+(7*2)+(6*2)+(5*0)+(4*0)+(3*7)+(2*4)+(1*9)=105
105 % 10 = 5
So 1422007-49-5 is a valid CAS Registry Number.
1422007-49-5Relevant articles and documents
Exploiting the Biocatalytic Toolbox for the Asymmetric Synthesis of the Heart-Rate Reducing Agent Ivabradine
Pedragosa-Moreau, Sandrine,Le Flohic, Alexandre,Thienpondt, Vivien,Lefoulon, Fran?ois,Petit, Anne-Marie,Ríos-Lombardía, Nicolás,Morís, Francisco,González-Sabín, Javier
, p. 485 - 493 (2017/02/10)
Several chemoenzymatic routes have been evaluated for the production of the heart-rate reducing agent ivabradine. Lipases and ω-transaminases have been identified as useful biocatalysts for the preparation of key enantiopure precursors. The lipase-catalysed kinetic resolution by alkoxycarbonylation of a racemic primary amine and subsequent chemical reduction of the resulting carbamate provided an N-methylated (S)-amine, one step away from ivabradine. Alternatively, the dynamic kinetic resolution by asymmetric bioamination of an aldehyde precursor enabled, in a four-step sequence, the preparative scale synthesis of enantiopure ivabradine in 50% overall yield. (Figure presented.).
